Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Solid Phase Peptide Synthesis (SPPS). These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced solid-phase synthesis and selective hydrogenolysis process for Buserelin and Goserelin. Reduces impurities and enhances supply chain reliability for pharmaceutical manufacturers.
Patent CN115991738A details a novel solid-phase synthesis for Plecanatide using orthogonal S-Tmp and Acm protection, ensuring high purity and commercial scalability for pharmaceutical manufacturers.
Patent CN106854235B reveals a novel solid-phase fragment method for Carbetocin, offering high purity and reduced solvent waste for pharmaceutical manufacturing.
Patent CN106892968B reveals a novel selective oxidation strategy for Linaclotide. Achieve high purity and yield with our scalable peptide manufacturing solutions.
Advanced solid-phase synthesis of Somaglutide via CN108359006B ensures high purity and yield. Discover cost-effective scalable manufacturing for global supply chains.
Patent CN104311639B details advanced solid-phase synthesis for somatostatin. Achieve higher purity and yield with optimized temperature control and resin selection.
Patent CN112028986A reveals a novel solid-phase method for semaglutide using dipeptide fragments to enhance purity and reduce industrial production costs.
Novel solid-phase method using ester-bond transamidation improves purity and yield for GLP-1 analogs. Cost-effective manufacturing solution for pharmaceutical intermediates.
Patent CN106146648B reveals a novel fragment condensation strategy for Abaloparatide, offering superior purity and yield for reliable peptide API intermediate manufacturing.
Novel solid-phase synthesis of Somaglutide using PEG-modified lysine building blocks reduces impurities and enhances scalability for pharmaceutical manufacturing.
Patent CN109180801B reveals a novel solid-phase synthesis for Semaglutide, enhancing crude purity and reducing production costs for pharmaceutical manufacturers.
Patent CN115181174A reveals a novel fragment coupling strategy for Tirzepatide, offering significant cost reduction and improved purity for pharmaceutical manufacturing.
Patent CN113880921B details a novel SPPS method for Bremelanotide using modified RinkAmide resin, achieving >99.8% purity and significant yield improvements for pharmaceutical manufacturing.
Patent CN115819493A reveals a novel acid-base washing method improving crude peptide purity by approximately 30%, offering cost-effective manufacturing for GLP-1 analogs.
Patent CN110964097B details a high-yield solid-phase fragment method for Exenatide, achieving over 99.7% purity and significantly reducing manufacturing costs.
Advanced all-solid-phase synthesis of Thymalfasin using amino resin and DMB-modified dipeptides. Delivers high purity and yield for reliable pharmaceutical intermediates supply.
Patent CN110894227A details a novel two-fragment solid-phase synthesis for Liraglutide, offering higher purity and reduced oily intermediates for reliable pharmaceutical manufacturing.
Patent CN113444150B reveals a novel solid-phase method for Plecanatide, offering superior yield and purity. Discover cost-effective manufacturing solutions for this GI drug.
Patent CN111378009A reveals a novel solid-phase synthesis for octreotide using aldehyde resin. This method simplifies processing, reduces side reactions, and offers cost-effective manufacturing solutions.
Advanced secondary cyclization method for Plecanatide synthesis ensures high yield and purity. Reliable supply chain partner for scalable pharmaceutical intermediate production.